Efficacy Evaluation of the Mahuang-Fuzi-Xixin Decoction in Combination with Shenmai Injection for Bradyarrhythmia Treatment: A Systematic Review and Meta-Analysis

BACKGROUND: Bradyarrhythmia treatment is often not timely enough, posing a potential threat to health. It is necessary to find a strategy with stable curative effects and high safety. Mahuang-Fuzi-Xixin (MFX) decoction and Shenmai injection (SMI) are compound Chinese Patent Medicines. Recent evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhang, Li, Yuxin, Yu, Tingting, Yan, Meihui, Li, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922179/
https://www.ncbi.nlm.nih.gov/pubmed/36785750
http://dx.doi.org/10.1155/2023/7280627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922179/
https://www.ncbi.nlm.nih.gov/pubmed/36785750
http://dx.doi.org/10.1155/2023/7280627

Ejemplares similares